MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells

BACKGROUND: Glioblastoma multiforme (GBM) is the most malignant brain tumor, and there is no effective treatment strategy. Patients with GBM have a median overall survival of only 14.6 months. Current treatment consists of safe and maximal surgical excision, followed by concurrent chemoradiotherapy...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Manag Res
Main Authors: Lee, Yi-Yen, Yarmishyn, Aliaksandr A, Wang, Mong-Lien, Chen, Hsiao-Yun, Chiou, Shih-Hwa, Yang, Yi-Ping, Lin, Chun-Fu, Huang, Pin-I, Chen, Yi-Wei, Ma, Hsin-I, Chen, Ming-Teh
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2018
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5903834/
https://ncbi.nlm.nih.gov/pubmed/29695934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S157261
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares